208 related articles for article (PubMed ID: 20348391)
41. High level of serum soluble interleukin-2 receptor at transplantation predicts poor outcome of allogeneic stem cell transplantation for adult T cell leukemia.
Shigematsu A; Kobayashi N; Yasui H; Shindo M; Kakinoki Y; Koda K; Iyama S; Kuroda H; Tsutsumi Y; Imamura M; Teshima T
Biol Blood Marrow Transplant; 2014 Jun; 20(6):801-5. PubMed ID: 24565990
[TBL] [Abstract][Full Text] [Related]
42. Definition, prognostic factors, treatment, and response criteria of adult T-cell leukemia-lymphoma: a proposal from an international consensus meeting.
Tsukasaki K; Hermine O; Bazarbachi A; Ratner L; Ramos JC; Harrington W; O'Mahony D; Janik JE; Bittencourt AL; Taylor GP; Yamaguchi K; Utsunomiya A; Tobinai K; Watanabe T
J Clin Oncol; 2009 Jan; 27(3):453-9. PubMed ID: 19064971
[TBL] [Abstract][Full Text] [Related]
43. How I treat adult T-cell leukemia/lymphoma.
Bazarbachi A; Suarez F; Fields P; Hermine O
Blood; 2011 Aug; 118(7):1736-45. PubMed ID: 21673346
[TBL] [Abstract][Full Text] [Related]
44. CD4
Makiyama J; Kobayashi S; Watanabe E; Ishigaki T; Kawamata T; Nakashima M; Yamagishi M; Nakano K; Tojo A; Watanabe T; Uchimaru K
Cancer Sci; 2019 Dec; 110(12):3746-3753. PubMed ID: 31642546
[TBL] [Abstract][Full Text] [Related]
45. Human T-cell lymphotropic virus type I-associated adult T-cell leukemia-lymphoma: new directions in clinical research.
Tsukasaki K; Tobinai K
Clin Cancer Res; 2014 Oct; 20(20):5217-25. PubMed ID: 25320371
[TBL] [Abstract][Full Text] [Related]
46. Japan Clinical Oncology Group (JCOG) prognostic index and characterization of long-term survivors of aggressive adult T-cell leukaemia-lymphoma (JCOG0902A).
Fukushima T; Nomura S; Shimoyama M; Shibata T; Imaizumi Y; Moriuchi Y; Tomoyose T; Uozumi K; Kobayashi Y; Fukushima N; Utsunomiya A; Tara M; Nosaka K; Hidaka M; Uike N; Yoshida S; Tamura K; Ishitsuka K; Kurosawa M; Nakata M; Fukuda H; Hotta T; Tobinai K; Tsukasaki K
Br J Haematol; 2014 Sep; 166(5):739-48. PubMed ID: 24931507
[TBL] [Abstract][Full Text] [Related]
47. Combination chemotherapy (RCM protocol: response-oriented cyclic multidrug protocol) for the acute or lymphoma type adult T-cell leukemia.
Uozumi K; Hanada S; Ohno N; Ishitsuka K; Shimotakahara S; Otsuka M; Chyuman Y; Nakahara K; Takeshita T; Kuwazuru Y
Leuk Lymphoma; 1995 Jul; 18(3-4):317-23. PubMed ID: 8535199
[TBL] [Abstract][Full Text] [Related]
48. Diagnostic Approaches and Established Treatments for Adult T Cell Leukemia Lymphoma.
Tsukasaki K; Marçais A; Nasr R; Kato K; Fukuda T; Hermine O; Bazarbachi A
Front Microbiol; 2020; 11():1207. PubMed ID: 32636814
[TBL] [Abstract][Full Text] [Related]
49. Distinct clinical features of infectious complications in adult T cell leukemia/lymphoma patients after allogeneic hematopoietic stem cell transplantation: a retrospective analysis in the Nagasaki transplant group.
Itonaga H; Taguchi J; Fukushima T; Tsushima H; Sato S; Ando K; Sawayama Y; Matsuo E; Yamasaki R; Onimaru Y; Imanishi D; Imaizumi Y; Yoshida S; Hata T; Moriuchi Y; Honda S; Miyazaki Y
Biol Blood Marrow Transplant; 2013 Apr; 19(4):607-15. PubMed ID: 23333533
[TBL] [Abstract][Full Text] [Related]
50. Recent advances in the treatment of adult T-cell leukemia-lymphomas.
Utsunomiya A; Choi I; Chihara D; Seto M
Cancer Sci; 2015 Apr; 106(4):344-51. PubMed ID: 25613789
[TBL] [Abstract][Full Text] [Related]
51. Newly identified poor prognostic factors for adult T-cell leukemia-lymphoma treated with allogeneic hematopoietic stem cell transplantation.
Tokunaga M; Uto H; Takeuchi S; Nakano N; Kubota A; Tokunaga M; Takatsuka Y; Seto M; Ido A; Utsunomiya A
Leuk Lymphoma; 2017 Jan; 58(1):37-44. PubMed ID: 27654808
[TBL] [Abstract][Full Text] [Related]
52. Treatment advances and prognosis for patients with adult T-cell leukemia-lymphoma.
Katsuya H; Ishitsuka K
J Clin Exp Hematop; 2017 Dec; 57(3):87-97. PubMed ID: 28592744
[TBL] [Abstract][Full Text] [Related]
53. Human T-cell leukaemia virus type I and adult T-cell leukaemia-lymphoma.
Ishitsuka K; Tamura K
Lancet Oncol; 2014 Oct; 15(11):e517-26. PubMed ID: 25281470
[TBL] [Abstract][Full Text] [Related]
54. Phase 2 study of the efficacy and safety of the combination of arsenic trioxide, interferon alpha, and zidovudine in newly diagnosed chronic adult T-cell leukemia/lymphoma (ATL).
Kchour G; Tarhini M; Kooshyar MM; El Hajj H; Wattel E; Mahmoudi M; Hatoum H; Rahimi H; Maleki M; Rafatpanah H; Rezaee SA; Yazdi MT; Shirdel A; de Thé H; Hermine O; Farid R; Bazarbachi A
Blood; 2009 Jun; 113(26):6528-32. PubMed ID: 19411628
[TBL] [Abstract][Full Text] [Related]
55. Differences in clinicopathological characteristics and major prognostic factors between B-lymphoma and peripheral T-lymphoma excluding adult T-cell leukemia/lymphoma.
Shimoyama M; Oyama A; Tajima K; Tobinai K; Minato K; Takenaka T; Konda C; Takeyama K; Kohno A; Narabayashi M
Leuk Lymphoma; 1993 Jul; 10(4-5):335-42. PubMed ID: 8220132
[TBL] [Abstract][Full Text] [Related]
56. Prognostic Significance of Tryptophan Catabolism in Adult T-cell Leukemia/Lymphoma.
Masaki A; Ishida T; Maeda Y; Suzuki S; Ito A; Takino H; Ogura H; Totani H; Yoshida T; Kinoshita S; Narita T; Ri M; Kusumoto S; Inagaki A; Komatsu H; Niimi A; Ueda R; Utsunomiya A; Inagaki H; Iida S
Clin Cancer Res; 2015 Jun; 21(12):2830-9. PubMed ID: 25788494
[TBL] [Abstract][Full Text] [Related]
57. Clinical and histopathological significance of PD-1 expression in cutaneous lesions of adult T-cell leukemia-lymphoma.
Higuchi M; Kuwatsuka Y; Murota H; Iwanaga M; Niino D
Pathol Res Pract; 2019 Jan; 215(1):40-49. PubMed ID: 30385085
[TBL] [Abstract][Full Text] [Related]
58. Frequent hepatic involvement in adult T cell leukemia: comparison with non-Hodgkin's lymphoma.
Yamada Y; Kamihira S; Murata K; Yamamura M; Maeda T; Tsukasaki K; Jubash T; Atogami S; Sohda H; Taguchi T; Tomonaga M
Leuk Lymphoma; 1997 Jul; 26(3-4):327-35. PubMed ID: 9322895
[TBL] [Abstract][Full Text] [Related]
59. Clinical significance of monocytosis and human monocytic colony-stimulating factor in patients with adult T-cell leukaemia/lymphoma.
Tokioka T; Shimamoto Y; Motoyoshi K; Yamaguchi M
Haematologia (Budap); 1994; 26(1):1-9. PubMed ID: 7959369
[TBL] [Abstract][Full Text] [Related]
60. A prospective phase II clinical trial with the use of zidovudine and interferon-alpha in the acute and lymphoma forms of adult T-cell leukemia/lymphoma.
Hermine O; Allard I; Lévy V; Arnulf B; Gessain A; Bazarbachi A;
Hematol J; 2002; 3(6):276-82. PubMed ID: 12522449
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]